Clinical trial
Early Sequential Nephron Blockade Versus Standard Diuretic Treatment in Acute Heart Failure
NCT04163588 is registered in ClinicalTrials.gov with Policlinico Casilino ASL RMB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Sequential Nephron Blockade Versus Standard Diuretic Treatment in Acute Heart Failure
- Lead sponsor
- Policlinico Casilino ASL RMB
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 1, 2019
- Completion date
- December 31, 2020
- Enrollment
- 310 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute heart failure